BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2574243)

  • 1. [Value of SLX and CA19-9 in the serum and tissue in colorectal cancer including the relation to Lewis blood type].
    Igarashi K
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2394-403. PubMed ID: 2574243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H
    J Gastroenterol; 2001 Mar; 36(3):166-72. PubMed ID: 11291879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers].
    Kawakami H; Sawabu N; Takemori Y; Okai T; Motoo Y; Satomura Y; Ohta H; Watanabe H; Matsuda N; Yamakawa O
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1141-8. PubMed ID: 2571740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma.
    Nakagoe T; Kusano H; Hirota M; Fukushima K; Hiratani K; Hara K; Tomita M
    Gastroenterol Jpn; 1991 Jun; 26(3):303-11. PubMed ID: 1716232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    Tumour Biol; 2001; 22(2):115-22. PubMed ID: 11125284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of serum sialyl Lewis X-i (SLX) in diffuse panbronchiolitis].
    Noguchi M; Nakatani T; Chohnabayashi N; Nakamori Y; Nakata K; Matsushita H; Tanimoto H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):317-25. PubMed ID: 2575680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sialyl Lewis(x)-I (SLX) as a tumor-associated carbohydrate antigen in sera in patients with gastric and colorectal cancer--evaluation according to clinico-pathological factors].
    Nakagoe T; Ishikawa H; Nakao H; Satoh T; Miyashita K; Yokota M; Takahira R; Kusano H; Shimizu T; Fukuda Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):819-25. PubMed ID: 2565704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in release mechanisms and distributions for sialyl Le(a) and sialyl Le(x) antigens in colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Tagawa Y
    Ann Surg Oncol; 2000 May; 7(4):289-95. PubMed ID: 10819369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
    Kobayashi H; Sumimoto K; Terao T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
    Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
    Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.
    Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Karino K; Endoh J; Kitao M
    Gynecol Obstet Invest; 1990; 29(3):214-8. PubMed ID: 1972688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer.
    Suzuki M; Ohwada M; Tamada T
    Gynecol Oncol; 1990 Mar; 36(3):371-5. PubMed ID: 1969379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables.
    Tabuchi Y; Deguchi H; Saitoh Y
    Cancer; 1988 Oct; 62(8):1605-13. PubMed ID: 3167774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies.
    Sakahara H; Saga T; Endo K; Kousaka T; Hosono M; Kobayashi H; Shirato M; Konishi J
    Br J Cancer; 1993 Nov; 68(5):920-5. PubMed ID: 8217607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Anticancer Res; 2002; 22(1A):451-8. PubMed ID: 12017332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in prognostic value between sialyl Lewis(a) and sialyl lewis(x) antigens in blood samples obtained from the drainage veins of the colorectal tumors.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Tagawa Y
    Cancer Lett; 2000 Oct; 159(2):159-68. PubMed ID: 10996727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contents of tissue CEA and CA19-9 in colonic polyp and colorectal cancer, and their clinical significance.
    Imamura Y; Yasutake K; Yoshimura Y; Oya M; Matsushita K; Tokisue M; Sashikata T
    Gastroenterol Jpn; 1990 Apr; 25(2):186-92. PubMed ID: 2347472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.